• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetics of imipenem in plasma and cerebrospinal fluid in patients with intracerebral hemorrhage.

作者信息

Kong Lingti, Xu Hongzhou, Wu Chenchen, Zhao Xuguang, Wu Xiaofei

机构信息

Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China.

Department of Emergency Internal Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China.

出版信息

Eur J Clin Pharmacol. 2018 Sep;74(9):1193-1195. doi: 10.1007/s00228-018-2488-3. Epub 2018 May 24.

DOI:10.1007/s00228-018-2488-3
PMID:29797035
Abstract
摘要

相似文献

1
Pharmacokinetics of imipenem in plasma and cerebrospinal fluid in patients with intracerebral hemorrhage.脑出血患者血浆和脑脊液中亚胺培南的药代动力学
Eur J Clin Pharmacol. 2018 Sep;74(9):1193-1195. doi: 10.1007/s00228-018-2488-3. Epub 2018 May 24.
2
Pharmacokinetics of imipenem in both plasma and peritoneal draining liquid in elder patients with perforated upper gastrointestinal tract.
Eur J Clin Pharmacol. 2020 Sep;76(9):1337-1339. doi: 10.1007/s00228-020-02904-1. Epub 2020 May 30.
3
Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects.健康受试者中新型β-内酰胺酶抑制剂雷巴他定与亚胺培南-西司他丁联合给药的肺内药代动力学。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.01411-17. Print 2018 Mar.
4
Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis.静脉注射舒巴坦-他唑巴坦联合亚胺培南-西司他丁在住院成人复杂性尿路感染（包括急性肾盂肾炎）中的药代动力学和耐受性。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01506-19.
5
The penetration of imipenem/cilastatin into ascitic fluid in patients with chronic liver disease.
J Antimicrob Chemother. 1994 Jan;33(1):163-7. doi: 10.1093/jac/33.1.163.
6
Clinical Pharmacokinetics and Pharmacodynamics of Imipenem-Cilastatin/Relebactam Combination Therapy.亚胺培南-西司他丁/雷巴他定联合治疗的临床药代动力学和药效学。
Clin Pharmacokinet. 2020 May;59(5):567-573. doi: 10.1007/s40262-020-00865-3.
7
Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.接受高剂量持续静脉-静脉血液滤过的烧伤重症监护病房患者中，亚胺培南/西司他丁的药代动力学
Pharmacotherapy. 2016 Dec;36(12):1229-1237. doi: 10.1002/phar.1866. Epub 2016 Dec 4.
8
Reversible black tongue: A little known side effect of imipenem/cilastatin and evidence for novel mode of action.可逆性黑舌：亚胺培南/西司他丁的一个鲜为人知的副作用及其作用机制的新证据。
J Clin Pharm Ther. 2020 Apr;45(2):370-372. doi: 10.1111/jcpt.13066. Epub 2019 Oct 17.
9
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection.在复杂性腹腔内感染患者中进行的瑞来巴坦与亚胺培南-西司他丁联用的2期剂量范围研究。
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6234-43. doi: 10.1128/AAC.00633-16. Print 2016 Oct.
10
Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.亚胺培南/西司他丁与阿米卡星联合哌拉西林治疗中性粒细胞减少患者感染的前瞻性、随机多中心研究。
Scand J Infect Dis Suppl. 1987;52:65-78.

引用本文的文献

1
Imipenem Population Pharmacokinetics: Therapeutic Drug Monitoring Data Collected in Critically Ill Patients with or without Extracorporeal Membrane Oxygenation.亚胺培南群体药代动力学：有或无体外膜肺氧合的危重症患者的治疗药物监测数据。
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.00385-20.

本文引用的文献

1
Pharmacokinetic/Pharmacodynamic Analysis of Meropenem for the Treatment of Nosocomial Pneumonia in Intracerebral Hemorrhage Patients by Monte Carlo Simulation.美罗培南治疗脑出血患者医院获得性肺炎的药代动力学/药效学分析：蒙特卡洛模拟法
Ann Pharmacother. 2017 Nov;51(11):970-975. doi: 10.1177/1060028017719715. Epub 2017 Jul 5.
2
Nosocomial Infections and Outcomes after Intracerebral Hemorrhage: A Population-Based Study.脑出血后医院感染与预后：一项基于人群的研究。
Neurocrit Care. 2016 Oct;25(2):178-84. doi: 10.1007/s12028-016-0282-6.
3
Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke.
出血性中风患者的万古霉素药代动力学参数
Neurocrit Care. 2016 Oct;25(2):250-7. doi: 10.1007/s12028-016-0264-8.
4
A Retrospective Study on the Incidence of Seizures among Neurosurgical Patients Who Treated with Imipenem/Cilastatin or Meropenem.一项关于接受亚胺培南/西司他丁或美罗培南治疗的神经外科患者癫痫发作发生率的回顾性研究。
Curr Pharm Biotechnol. 2014;15(8):685-90. doi: 10.2174/1389201015666140717090143.
5
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants.在一项大型回顾性住院婴儿队列研究中，美罗培南与亚胺培南/西司他丁治疗相关的不良事件。
Pediatr Infect Dis J. 2013 Jul;32(7):748-53. doi: 10.1097/INF.0b013e31828be70b.
6
The use of carbapenems in the treatment of serious infections.碳青霉烯类药物在严重感染治疗中的应用。
J Intensive Care Med. 2009 Jul-Aug;24(4):230-41. doi: 10.1177/0885066609335660. Epub 2009 Jul 17.
7
Safety of imipenem/cilastatin in neurocritical care patients.亚胺培南/西司他丁在神经重症监护患者中的安全性。
Neurocrit Care. 2009;10(3):403-7. doi: 10.1007/s12028-008-9170-z. Epub 2008 Dec 31.
8
Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit.美罗培南与亚胺培南/西司他丁作为重症监护病房严重细菌感染经验性单药治疗的比较
Clin Microbiol Infect. 2000 Jun;6(6):294-302. doi: 10.1046/j.1469-0691.2000.00082.x.
9
Comparative pharmacokinetics of the carbapenems: clinical implications.碳青霉烯类药物的比较药代动力学：临床意义。
Clin Pharmacokinet. 2000 Sep;39(3):185-201. doi: 10.2165/00003088-200039030-00002.
10
Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections.亚胺培南与西司他丁（泰能）在中枢神经系统感染儿童中的脑脊液穿透率
Antimicrob Agents Chemother. 1986 Apr;29(4):670-4. doi: 10.1128/AAC.29.4.670.